# A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

> **NCT01851512** · PHASE1 · COMPLETED · sponsor: **Dong-A Pharmaceutical Co., Ltd.** · enrollment: 27 (actual)

## Conditions studied

- Infertility
- Induction of Ovulation

## Interventions

- **DRUG:** T-R (Test-Reference drug)
- **DRUG:** R-T (Reference-Test drug)

## Key facts

- **NCT ID:** NCT01851512
- **Lead sponsor:** Dong-A Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-08
- **Final completion:** 2011-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2013-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851512, "A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01851512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*